PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Phase Ib trial including investigating the combination of nab-paclitaxel and cisplatin in
patients diagnosed with peritoneal carcinomatosis related to pancreatic, oeso-gastric,
ovarian cancer or primitive peritoneal mesothelioma.